CODX vs NWS · rev $3.9M vs rev $9.03B
Co-Diagnostics, Inc. Common Stock (CODX) versus NWS (NWS) — a side-by-side from cached financials, not a winner call.
Co-Diagnostics, Inc. Common Stock (CODX) is a medical devices company listed on US.
NWS (NWS) common stock.
Latest reported CODX revenue for 2024-12-31 was $3.9M. Net income was -$37.6M. Revenue was down 42.5% from 2023-12-31 to 2024-12-31. CODX currently screens at market cap $31.4M.
Latest reported NWS revenue for 2026-06-30 was $9.03B. Net income was $573.0M. Revenue was up 6.8% from 2025-06-30 to 2026-06-30. NWS currently screens at market cap $0.
CODX currently screens at market cap $31.4M. NWS currently screens at market cap $0.
Not investment advice. Open the CODX and NWS stock pages for the full models.
Not investment advice.